SCIENTIFIC BACKGROUND

TNFRSF1A

Category:

TNF receptor-1-associated periodic syndrome (TRAPS) is a rare congenital periodic fever syndrome and it is inherited in an autosomal dominant manner with reduced penetrance. On average, the first symptoms appear in the 3rd year of life, but the disease may manifest in adulthood. TRAPS can affect patients of any ethnicity. Clinically, TRAPS is characterized by recurrent febrile episodes lasting from about 7 days to several weeks. The attacks are often accompanied by severe abdominal pain, myalgias, arthralgias, conjunctivitis and/or periorbital edema, and migratory erysipelas-like erythema. Between relapses, most patients are asymptomatic. However, subclinical inflammation leads to amyloidosis in approximately 20% of untreated or late-diagnosed TRAPS patients, primarily affecting the kidneys. Symptomatic therapy is the administration of steroids. The soluble TNF-α receptor etanercept may represent an alternative therapeutic option, especially in the presence of a receptor cleavage defect. Patients with mutations of the cysteine residues of the TNF receptor show a good clinical and laboratory response to therapy with anakinra (IL-1 receptor blocker).

 

The cause of the disease is variants in the TNFRSF1A gene (TNF receptor superfamily-1A), which encodes the cell membrane-bound receptor TNFR1 (also TNFR p55). The binding of TNF-α to the receptor leads to cytokine secretion, leukocyte activation, and fever, among other effects. As a negative feedback loop, the extracellular portion of the receptor is shed from the surface after stimulation and traps free TNF-α in soluble form. Almost all of the more than 70 known mutations (predominantly missense mutations) are located in exons 2-4 and 6, which encode the first two extracellular receptor domains and the cleavage site.

 

References

Gattorno et al. 2019, Ann Rheum Dis 78:1025 / ter Haar et al. 2015, Ann Rheum Dis 74:1636 / Lainka et al. 2009, Rheumatology 48:987 / Aksentijevich et al. 2001, Am J Hum Genet 69:301

GENES

TNFRSF1A
How to order

LATEST ARTICLES

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more